2023

1. Reduction of disease activity, corticosteroids use, and healthcare resource utilisation in patients with systemic lupus erythematosus treated with belimumab in clinical practice settings: OBSErve Spain multicentre study

   Reumatologia Clinica, Vol. 19, Núm. 6, pp. 312-318